References
1a
Davis AP.
Chem. Soc. Rev.
1993,
243
1b
Li Y.
Dias JR.
Chem. Rev.
1997,
97:
283
1c
Wallimann P.
Marti T.
Fürer A.
Diederich F.
Chem. Rev.
1997,
97:
1567
1d
Kolehmainen E.
Tamminen J.
Molecules
2001,
6:
21
1e
Virtanen E.
Kolehmainen E.
Eur. J. Org. Chem.
2004,
3385
2
Bortolini O.
Cora V.
Fantin G.
Medici A.
Chem. Lett.
1996,
335
3
Burrows CJ.
Sauter RA.
J. Inclusion Phenom.
1987,
5:
117
4
Kinneary JF.
Roy TM.
Albert JS.
Yoon H.
Wagler TR.
Shen L.
Burrows CJ.
J. Inclusion Phenom.
1989,
7:
155
5
McKenna J.
McKenna JM.
Thornthwaite DW.
J. Chem. Soc., Chem. Commun.
1977,
809
6a
Tamminen J.
Kolehmainen E.
Haapala M.
Linnanto J.
Synthesis
2000,
1464 ; and references cited therein
6b
Pandey PS.
Rai R.
Singh RB.
J. Chem. Soc., Perkin Trans. 1
2002,
918 ; and references cited therein
6c
Pandey PS.
Singh RB.
Tetrahedron
2002,
58:
355
7
Davis AP.
Wareham RS.
Angew. Chem. Int. Ed.
1999,
38:
2978 ; and references cited therein
8a
Kohmoto S.
Sakayori K.
Kishikawa K.
Yamamoto M.
J. Chem. Soc., Perkin Trans. 2
1999,
833
8b
Potluri VK.
Maitra U.
J. Org. Chem.
2000,
65:
7764 ; and references cited therein
9
Salunke DB.
Hazra BG.
Pore VS.
Bhat MK.
Nahar PB.
Deshpande MV.
J. Med. Chem.
2004,
47:
1591
10a
Lakhvich FA.
Lis LG.
Akhrem AA.
Russ. Chem. Rev.
1984,
53:
582
10b
Burbiel J.
Bracher F.
Steroids
2003,
68:
287
10c
Fouace S.
El kihel L.
Dherbomez M.
Letourneux Y.
Bioorg. Med. Chem. Lett.
2001,
11:
3011
11a
Odds FC.
Brown AJP.
Gow NAR.
Trends Microbiol.
2003,
11:
272 ; and references cited therein
11b
Cooper AB.
Wright JJ.
Ganguly AK.
Desai J.
Loebenberg D.
Parmeqiani R.
Feingold DS.
Sud IJ.
J. Chem. Soc., Chem. Commun.
1989,
898
12a
Rostovtsev VV.
Green LG.
Fokin VV.
Sharpless KB.
Angew. Chem. Int. Ed.
2002,
41:
2596
12b
Tornoe CW.
Christensen C.
Meldal M.
J. Org. Chem.
2002,
67:
3057
13
Suarez PL.
Gandara Z.
Gomez G.
Fall Y.
Tetrahedron Lett.
2004,
45:
4619
14
Suh BC.
Jeon HB.
Posner GH.
Silverman SM.
Tetrahedron Lett.
2004,
45:
4623
15
Chittaboina S.
Xie F.
Wang Q.
Tetrahedron Lett.
2005,
46:
2331
16
Davis AP.
Perez-Payan MN.
Synlett
1999,
991
17
Typical Experimental Procedure.
A solution of azide (1 mmol) and propargyl ester of bile acid (0.95 mmol) in t-BuOH (10 mL) was stirred at 60 °C for 15 min. Then, CuSO4·5H2O (5 mol% in 0.5 mL of H2O) and sodium ascorbate (20 mol% in 0.5 mL of H2O) were added to the reaction mixture and it was stirred at 60-65 °C for 3-12 h. The solvent was evaporated under reduced pressure to afford a crude product, which on purification by column chromatography on silica gel gave pure dimeric compounds containing 1,2,3-triazole moiety in 92-96% yield.
Spectral Data of Compound 8.
Yield 92%; mp 100-102 °C (EtOAc-hexane); [α]D
31 = +11.0 (c 0.6, CHCl3); TLC: R
f
= 0.56 (MeOH-CH2Cl2, 1:9). IR (CHCl3): 3431, 1728 cm-1. 1H NMR (200 MHz, CDCl3): δ = 0.66 (s, 3 H), 0.70 (s, 3 H), 0.91-1.00 (12 H), 3.61 (m, 1 H), 3.66 (s, 3 H, OCH3), 3.96 (br s, 1 H), 4.02 (br s, 1 H), 4.47 (m, 1 H), 5.20 (s, 2 H), 7.68 (s, 1 H, triazole H) ppm. 13C NMR (50 MHz, CDCl3): δ = 12.6, 17.2, 23.0, 23.1, 23.6, 25.9, 26.1, 26.8, 27.0, 27.4, 27.9, 28.6, 30.3, 30.6, 30.8, 31.1, 33.5, 33.6, 33.8, 34.0, 34.2, 35.1, 35.6, 35.9, 36.3, 42.0, 42.6, 46.4, 46.5, 47.0, 47.2, 47.9, 48.2, 51.4, 57.5, 61.0, 71.6, 72.9, 122.1, 142.2, 174.1, 174.6 ppm. MS (LC-MS): m/z calcd: 862.62 [M+ + 1]; found: 862.8 [M+ + 1], 884.8 [M+ + Na]. Anal. Calcd for C52H83N3O7: C, 72.44; H, 9.70; N, 4.87. Found: C, 72.17; H, 10.02; N, 4.60.
18
Li C.
Peters AS.
Meredith EL.
Allman GW.
Savage PB.
J. Am. Chem. Soc.
1998,
120:
2961
19
Spectral Data of Compound 13.
Yield 96%; mp 136-138 °C (EtOAc-hexane); [α]D
31 = +9.84 (c 0.61, CHCl3); TLC: R
f
= 0.52 (MeOH-CH2Cl2, 0.5:9). IR (CHCl3): 3419, 1728 cm-1. 1H NMR (200 MHz, CDCl3): δ = 0.65 (s, 3 H), 0.66 (s, 3 H), 0.90-0.98 (12 H), 3.59 (m, 2 H), 3.96 (br s, 2 H), 4.31 (t, J = 7.07 Hz, 2 H, OCH2), 5.21 (s, 2 H), 7.60 (s, 1 H, triazole H) ppm. 13C NMR (75 MHz, CDCl3): δ = 12.3, 17.1, 17.4, 23.0, 23.6, 26.0, 26.9, 27.1, 27.5, 28.4, 30.2, 30.6, 31.0, 32.4, 33.3, 33.9, 35.1, 35.8, 36.1, 42.0, 46.3, 46.8, 47.9, 50.7, 57.3, 60.3, 63.5, 71.4, 72.9, 123.6, 142.7, 174.1 ppm. MS (LC-MS): m/z calcd: 834.63 [M+ + 1]; found: 834.7 [M+ + 1], 856.7 [M+ + Na]. Anal. Calcd for C51H83N3O6: C, 73.43; H, 10.03; N, 5.04. Found: C, 73.11; H, 9.82; N, 4.82.
20
Salunke DB.
Hazra BG.
Gonnade RG.
Bhadbhade MM.
Pore VS.
Tetrahedron
2005,
61:
3605
21
Spectral Data of Compound 16.
Yield 92%; mp 156-157 °C (EtOAc-hexane); [α]D
31 = +20.0 (c 0.61, CHCl3); TLC: R
f
= 0.4 (MeOH-CH2Cl2, 0.5:9). IR (CHCl3): 3411, 1728, 1674 cm-1. 1H NMR (200 MHz, CDCl3): δ = 0.67 (s, 3 H), 0.73 (d, J = 5.93 Hz, 3 H), 0.89 (s, 3 H), 0.96 (d, J = 5.69 Hz, 3 H), 1.18 (s, 3 H), 1.27 (s, 3 H), 2.00 (s, 3 H), 2.10 (s, 3 H), 3.45 (m, 1 H), 3.66 (s, 3 H, OCH3), 3.84 (br s, 1 H), 3.96 (br s, 1 H), 3.40 (m, 1 H), 5.02 (br s, 1 H) 5.24 (d, J = 2.02 Hz, 2 H, OCH2), 5.91 (d, J = 9.98 Hz, C-11 H attached to triazole), 7.83 (s, 1 H, triazole H) ppm. 13C NMR (75 MHz, CDCl3): δ = 11.2, 12.4, 17.2, 18.4, 21.2, 21.3, 22.5, 23.2, 24.0, 26.5, 27.1, 27.4, 28.2, 29.5, 30.1, 30.3, 30.8, 30.9, 31.0, 31.2, 34.6, 34.7, 35.1, 35.2, 35.4, 37.4, 38.1, 39.6, 41.5, 41.7, 42.2, 44.2, 46.5, 46.8, 47.4, 51.4, 52.4, 56.5, 57.4, 65.7, 68.3, 70.4, 71.9, 72.9, 73.2, 126.0, 142.7, 169.8, 170.5, 174.0, 174.3, 204.1 ppm. MS (LC-MS): m/z calcd: 992.61 [M+ + 1]; found: 992.7 [M+ + 1], 1014.7 [M+ + Na]. Anal. Calcd for C56H85N3O12: C, 67.78; H, 8.63; N, 4.23. Found: C, 67.43; H, 8.71; N, 3.97.